RE:RE:35% CRR on PapillaryShack, while I am not a pom pom waving fan of current management I am fine with them managing the parameters of the FDA submission and being uber conservative on their CR projections. To those that wonder how this "to good to be true" opportunity has flown under the radar you may, and I mean may, only need to look no further than what would be in the immediate interest of their many previous "partners", formal or otherwise. Somebody wants this stock under 50 mil US market cap and absolutely under $1.00. That excludes 90% of institutional buying and squashes any upward momentum. Given the tired and war wary shareholder base, an 80 cent buyout of a $5.00 - $10.00 property looks very appealing. Too bad management couldn't disclose the rough dimensions of their multiple offers. I suspect that if they did the SP would go Thermo-Nuclear. Instead we drudge along at 38 cents. I wonder what that independent 3rd party market assessor values the MCNA franchise at? I'll bet it ain't 50 mil.